It is recommended that healthcare providers assess a patients request for this medication in relation to the desired positive effects on a chronic disease, rather than solely on body image (achievement of a desired weight or clothing size)
The side effects of Melanotan II A study of 28 people aged 18 to 64 by the British Journal of Dermatology details some of the side effects they commonly experienced
In the STEP UP clinical trial, the 7.2-mg dose demonstrated a mean weight loss of 20.7% at 72 weeks, compared with a reduction of 17.5% with the previously approved semaglutide (Wegovy) injection (2.4 mg) and 2.4% with placebo
Experimental results demonstrated that apelin-13, an endogenous ligand of the G protein-coupled receptor angiotensin II protein J (APJ), increased DRP1 expression, inhibited fusion-related protein expression, and stimulated VSMC mitophagy and abnormal proliferation, which exacerbated the development of atherosclerosis [227]
H.RykkenJ
See the dedicated CJC-1295 + Ipamorelin stack guide for the full protocol breakdown
